申请人:GENENTECH, INC
公开号:US20020119994A1
公开(公告)日:2002-08-29
The invention relates to novel compounds having formula (I)
1
wherein Cy, X, Y, L and R
1-6
are as defined herein. The compounds bind CD11/CD10 adhesion receptors such as Lymphocyte Function-associated Antigen-1 (LFA-1) and are therefore useful for treating disorders mediated by LFA-1 such as inflammation and autoimmune diseases.
该发明涉及具有式(I)的新化合物,其中Cy、X、Y、L和R1-6的定义如本文所述。这些化合物结合CD11/CD10黏附受体,如淋巴细胞功能相关抗原-1(LFA-1),因此可用于治疗由LFA-1介导的炎症和自身免疫性疾病等疾病。